CISPLATIN
Substance profile for UNII Q20Q21Q62J, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from NCI/CADD chemical resolverSubstance Identity#
- UNII
- Q20Q21Q62J
- Preferred term
- CISPLATIN
- Registry number
- 15663-27-1
- EC number
- 239-733-8
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- 2Cl.Pt.2H3N
Structure render from NCI/CADD chemical resolverChemical And Database Identifiers#
- SMILES
- N.N.[Cl-].[Cl-].[Pt++]
- RxCUI
- 2555
- PubChem
- 0
- NCIt
- C376
- INN ID
- 4426
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CISPLATIN | ACTIVE INGREDIENT | Q20Q21Q62J | CISPLATIN INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | |
| CISPLATIN | ACTIVE MOIETY | Q20Q21Q62J | CISPLATIN INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | |
| cisplatin | ACTIVE MOIETY | Q20Q21Q62J | PLATINOL (CISPLATIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CORDEN PHARMA LATINA S.P.A.] | 4 | |
| cisplatin | ACTIVE INGREDIENT | Q20Q21Q62J | PLATINOL (CISPLATIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CORDEN PHARMA LATINA S.P.A.] | 4 | |
| CISPLATIN | ACTIVE INGREDIENT | Q20Q21Q62J | CISPLATIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| CISPLATIN | ACTIVE MOIETY | Q20Q21Q62J | CISPLATIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| cisplatin | ACTIVE INGREDIENT | Q20Q21Q62J | CISPLATIN INJECTION, SOLUTION [WG CRITICAL CARE, LLC] | 3 | |
| cisplatin | ACTIVE MOIETY | Q20Q21Q62J | CISPLATIN INJECTION, SOLUTION [WG CRITICAL CARE, LLC] | 3 | |
| cisplatin | ACTIVE INGREDIENT | Q20Q21Q62J | PLATINOL-AQ (CISPLATIN) INJECTION, SOLUTION [CORDEN PHARMA LATINA S.P.A.] | 3 | |
| cisplatin | ACTIVE MOIETY | Q20Q21Q62J | PLATINOL-AQ (CISPLATIN) INJECTION, SOLUTION [CORDEN PHARMA LATINA S.P.A.] | 3 | |
| CISPLATIN | ACTIVE INGREDIENT | Q20Q21Q62J | CISPLATIN INJECTION [MYLAN INSTITUTIONAL LLC ] | 1 | |
| CISPLATIN | ACTIVE MOIETY | Q20Q21Q62J | CISPLATIN INJECTION [MYLAN INSTITUTIONAL LLC ] | 1 | |
| CISPLATIN | ACTIVE INGREDIENT | Q20Q21Q62J | CISPLATIN INJECTION [PFIZER LABORATORIES DIV PFIZER INC.] | 1 | |
| CISPLATIN | ACTIVE MOIETY | Q20Q21Q62J | CISPLATIN INJECTION [PFIZER LABORATORIES DIV PFIZER INC.] | 1 | |